ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GPL Graft Polymer (uk) Plc

0.145
0.00 (0.00%)
21 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Graft Polymer (uk) Plc LSE:GPL London Ordinary Share GB00BMD1Z199 ORD GBP0.001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.145 0.14 0.15 0.145 0.145 0.15 0.00 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Services, Nec 542k -2.71M -0.0260 -0.05 145.74k
Graft Polymer (uk) Plc is listed in the Business Services sector of the London Stock Exchange with ticker GPL. The last closing price for Graft Polymer (uk) was 0.15p. Over the last year, Graft Polymer (uk) shares have traded in a share price range of 0.125p to 4.25p.

Graft Polymer (uk) currently has 104,097,299 shares in issue. The market capitalisation of Graft Polymer (uk) is £145,736 . Graft Polymer (uk) has a price to earnings ratio (PE ratio) of -0.05.

Graft Polymer (uk) Share Discussion Threads

Showing 51 to 69 of 75 messages
Chat Pages: 3  2  1
DateSubjectAuthorDiscuss
14/5/2024
10:46
It actually stands half a chance now that Zomer is no longer involved.
flc
09/5/2024
08:12
Fund raise on the way as they need to raise, question is at what price in these dire markets as many recent raises have been at big discounts
pre
02/5/2024
11:11
Think I may have stumbled across an extremely interesting minnow here. Following the RNS put out this morning announcing the appointment of Anthony Tennyson as the new CEO there could be very exciting times ahead. His CV looks exceptional and has also a background in finance having worked at Merrill Lynch and Bank of Ireland both blue chip names. Besides that his career has been in Life Sciences and this is exactly what this company needs. With such a tiny market cap there is huge potential upside here.
highlyregal
01/5/2024
09:23
Direction with new investors -

Graft Bio division continues to see ongoing interest and the potential demand we are witnessing provides encouraging possibilities for the future. We anticipate that this may position the Company as a multi-sector specialist chemical firm offering expertise and R&D capabilities to develop high-end solutions for refiners, compounders and processors, rather than solely producing them in-house.

Focus now on this division

tomboyb
29/4/2024
12:37
RNS indicating new investors have stuck another 3100k in -
tomboyb
15/4/2024
11:35
135k market cap - ?
tomboyb
15/3/2024
12:09
market cap £166K is that all it takes nowadays to get listed
the bull
15/3/2024
10:56
https://www.linkedin.com/in/nicholas-nelson-05a926118?originalSubdomain=ukNew director provides 100k loan
mally6
27/12/2023
09:51
I warned you all another Roby Scam .
goforgold1
22/12/2023
08:02
Nowhere by the looks of it!
flc
09/10/2023
08:08
Yet another load of tosh...where is the money?
flc
27/9/2023
08:03
Beware, this is following the same pattern as MXC...lots of new contracts, no cash and constant fund raises,
flc
26/9/2023
15:08
Looks like MGC are in trouble Roby Zomer looks like he'll be taking it private.
hatfullofsky
21/9/2023
10:55
Gofor, I'm not convinced it's a fraud but the Concert party does worry me, main shareholders and directors own 60% so they can basically do what they want, sell, take it private etc but I think they benefit from a full LSE not AIM listingRoby Zomer is Founder and CEO of MGC Pharma but only holds 1% - Premier own 10%)Get the orders in and the revenue, large order book the raise and dilute the Concert to under 40%
hatfullofsky
05/9/2023
09:43
Just looking in, as the chart seems very interesting. However from my quick look it seems a bit like a 'jam tomorrow' company?Is this an Israeli company?
cyberbub
30/8/2023
08:12
Another supply agreement.

That's the 2nd one in 7 days.

Shares are definitely worth much more than their price.

z1co
24/8/2023
15:15
Do a company search on this scumbag . Notice the area were the number comes from same as deals ..MGC Pharmaceuticals Ltd Roby Zomer CEO & Managing Director +61 8 6382 3390 info@mgcpharma.com.au
goforgold1
24/8/2023
07:52
There were plenty of figures in that rns but understand your cautioun. For the mcap I believe it's "cheap" but who knows. Time will tell.
babbler
23/8/2023
10:05
Babbler...I don't totally agree with all of GFG1's comments but there is a complex network behind the scenes here and I would advise any investors to tread carefully and DTOR. There's always lots of good news flow but limited info on figures and they do like to raise cash at fairly regular intervals.
flc
Chat Pages: 3  2  1

Your Recent History

Delayed Upgrade Clock